Primary breast lymphoma (PBL) that is localized without lymph node involvement is considered limited-stage disease (stage 1 or 2). The good news is that limited-stage PBL typically has a better five-year survival rate compared to other types of systemic lymphomas.
Treatment for PBL is generally similar to other non-Hodgkin Show Full Answer
Primary breast lymphoma (PBL) that is localized without lymph node involvement is considered limited-stage disease (stage 1 or 2). The good news is that limited-stage PBL typically has a better five-year survival rate compared to other types of systemic lymphomas.
Treatment for PBL is generally similar to other non-Hodgkin lymphomas and typically involves a combination of localized radiation and systemic chemotherapy. The specific treatment plan will depend on your individual case and staging. While lymphoblastic lymphoma can involve both blood and bone marrow, when the disease is confined to the breast tissue without other organ involvement, your medical team will determine if central nervous system prophylaxis (spinal injections) is necessary based on your specific case details. It's important to discuss your individual treatment plan with your healthcare provider as they can best evaluate your specific situation and risk factors.
April 3, 2025
Join
Your Privacy Choices
